News
2d
News Medical on MSNKey Enzyme Target Found to Combat Deadly Brain CancersCOLUMBUS, Ohio – Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the ...
The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...
A fundraiser to benefit brave 4-year-old township resident Scarlett Griffith and heighten awareness about the rare genetic ...
Research on the biological basis of addiction has found that the critical epigenetic enzyme histone deacetylase 5 (HDAC5) limits the expression of the gene Scn4b, regulating neuronal activity and ...
The global diagnostic exosome biomarkers market is poised for significant growth, with market demand projected to reach USD 196.8 million by the end of 2023. According to recent industry forecasts, ...
Parenteral nutrition (PN) is lifesaving for patients with short bowel syndrome and other gastrointestinal disorders, however long-term use may lead to complications including hepatosteatosis and ...
RIKEN researchers have demonstrated the protective effects of a specific genetic mutation against Alzheimer's disease in ...
Surgical management of rare genetic digestive disorder in private hospital restores health of 12-year-old girl in Karnataka.
The NHS can’t afford all the latest miracle drugs. A quango decides who misses out ...
2d
Verywell Health on MSNOhtuvayre: The First Novel COPD Treatment Approved in Over a DecadeOhtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...
SaveHealth assesses the relative benefits of Zoloft vs. Lexapro, comparing their usage, effectiveness, tolerability, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results